NMR Diagnostics Target customers in biotech, food, oils, pharma, and cannabis sectors leveraging WaveGuide’s rapid, non-destructive, in-situ NMR capabilities for on-site screening and quality control to replace slower lab-based analysis.

Portable Platform Leverage the battery-powered, compact Formμla device to address field and on-site testing opportunities at manufacturing plants, distribution centers, and research facilities seeking portable analytical solutions.

FDA-Approved Benchmarks Highlight the 513(g) FDA predicate devices for tuberculosis and ovarian cancer to build credibility with hospital systems, clinical labs, and biotech firms pursuing validated point-of-care diagnostics.

Low Scale Entry With a lean team and a focus on specialized markets, pursue early adopters in niche segments (BioPharma, Cannabis, specialty oils) where rapid, reagent-free analysis can differentiate offerings and justify higher value pricing.

Cross-Sell Opportunities Position WaveGuide as a platform play for customers requiring multiple material analyses (biological samples, foods, lubricants, and cannabinoids) to expand from single-application devices to multi-market deployments.